Contact us
News

Keep you updated

with the latest info of XtalPi

Explore all resources
  • News
XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
  • News
XtalPi Names New COO for U.S. Operations, Bringing Its Autonomous Labs to Boston in Continued Global Expansion
  • News
XtalPi Announces Research Collaboration with Janssen
  • News
Fierce Medtech names XtalPi as one of its “Fierce 15” Med Tech Companies of 2021
  • News
XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target
  • News
Research Collaboration between XtalPi Inc and Acerand Therapeutics to develop potential novel anti-cancer therapies using High-precision Physics-based model and Machine Learning

XtalPi uses AI, quantum physics, and automation to speed up drug discovery and materials research. They provide integrated solutions to streamline R&D processes, reducing time and waste in developing new therapies.

© 2024 All Rights Reserved, Privacy Policy

Search XtalPi

  • Case Studies, Software, XFEP
Development of small molecule selective inhibitors with XFEP
  • Case Studies, Software, XFEP
Discovery of Novel Non-covalent GPX4 Potent Hits with XFEP
  • Case Studies, Software, XFEP, XmolGen
Discovery of Novel Leads Targeting a Highly Flexible Allosteric Site with XMolGen and XFEP
Get started